Nasdaq GlobeNewswire

Global Print Management Software Solution, PaperCut, Expands Presence in the United Kingdom

Del

New UK team, office aims to address increasing demand from EMEA businesses for print management solutions

BRACKNELL, United Kingdom, Dec. 21, 2017 (GLOBE NEWSWIRE) -- PaperCut, a global print management software company, today announced their expansion within the United Kingdom (UK) to ensure its EMEA customers continue to receive the high-quality service and business agility that PaperCut is known for. The organization currently has over 19,000 customers in EMEA, which contribute to more than 40 percent of the company's revenue. To address the company's increasing customer base within the region, PaperCut has established an office located in Bracknell, England, which will allow the company to provide consistent, high-quality support across local time zones, languages and geographies.

Headquartered in Melbourne, Australia, the Bracknell office joins Papercut as its third global location, following PaperCut's expansion in the U.S. with an office space in Portland, Oregon, which opened May 2017. The UK has proven to be a market with excellent growth opportunity for PaperCut, and is the first of multiple cities in Europe where the company plans to expand its presence. Since April 2017, the company has hired more than a dozen industry and technology specialists to ensure the office is well-staffed with experts in the field.

The most recent hires to the Bracknell office include former Nuance Communications, Hewlett Packard Enterprise and Dell managers, who bring experience in strategic leadership, channel management, professional services and regional support. As an international company, the UK-based team that PaperCut has carefully selected PaperCut's carefully chosen team speaks more than 22 languages and brings a diverse background of expertise.

"The EMEA region represents an important part of PaperCut's future-in fact, many companies across the region have helped us innovate and shape our products," said Chris Dance, co-founder and CEO of PaperCut. "It's our responsibility and philosophy to continue to foster and build upon those relationships through delivery. That's why we're proud to continue to invest local resources and expertise in the UK to help deliver personalized and quality service that our customers and partners require."

As part of the establishment of the UK office, employees contribute to a variety of unique departments and functions of operation and support, including:

  • Channel Management -Supports PaperCut's network of Authorized Solution Centers (ASCs) across EMEA
  • Partner Alliances -Strategic account and product management for print device manufacturers
  • Support -In-depth, Tier 3 product support for PaperCut's thousands of EMEA customers
  • Technical Services -Configuration and collaboration accomplished via the Solution Architect team, which working with channel partners and customers to provide the most effective print system solutions
  • Customer Care -Addresses pre-sales questions from PaperCut's customers and channel partners
  • Order Processing -Efficiently processes EMEA orders in the time zone.

"At PaperCut, our employees are responsible for providing high-quality, unique customer and partner service," Steve Holmes, EMEA site lead and channel director. "Our first priority is to contribute value to our customers and channel partners in the region, while simultaneously growing PaperCut's global presence. We're already seeing the impact that the local team is having with our continued expansion and overall momentum in the UK and throughout Europe."

Located 34 miles west of central London, the Bracknell office initiates PaperCut's plans for continued expansion to ensure comprehensive coverage of the vast Europe, Middle East and African regions. The 105 square meter office offers a temporary workspace for the UK employees while a more permanent location is being finalized, which is projected to open in Q2 2018.

Looking forward, PaperCut plans to hire an additional Channel Manager and Key Account Manager before the end of 2017. This expansion solidifies the company's ongoing commitment to supporting their customers and partners-both existing and future-in the region. To learn more about career opportunities with PaperCut, please visit papercut.com/about/careers.

About PaperCut Software
Around the world, workplaces are wrestling with printing costs and print management complexity. PaperCut is solving those problems, one workplace at a time. Since 1998, PaperCut has helped 50 million users in 175 countries save trillions of pages of paper. With PaperCut in their print environment, IT managers solve their nagging print problems once and for all. How? Its two software solutions - PaperCut MF and PaperCut NG - are cross-platform and vendor neutral. That means they work with any printer and any operating system. Plus, both solutions feature ground-breaking technology such as mobility print, secure print release, and rich reporting tools. Businesses of all shapes, sizes and industry benefit from the control, security and financial and environmental savings that PaperCut software was built for. Learn more at www.papercut.com.

Media Contact
Meghan Brown
10Fold Communications for PaperCut
papercut@10fold.com 415-800-5389




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Papercut Services North America LLC via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Partnership Between Zaiput Flow Technologies and ThalesNano Set to Improve Process Intensification18.10.2018 15:21Pressemelding

BUDAPEST, Hungary and WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zaiput Flow Technologies, a global leader in separation, and ThalesNano, the world leader in bench-top flow chemistry reactors, recently signed a distribution agreement and entered into a technology partnership that exploits the benefits of their combined technologies. Under the distribution Zaiput liquid-liquid phase separators and back pressure regulators are available via ThalesNano in Europe and a number of other countries on a non-exclusive basis, either separately or as part of a bundled offering with ThalesNano’s own microflow reactors. Within the framework of the technology partnership the companies will collaborate to promote adoption of the combined use of their technologies. “We are very excited to work with ThalesNano to offer better-integrated flow chemistry systems to our customers and streamline the work of both novice and experienced users in the flow chemistry space,” said Zaiput CEO, Dr. Andrea Ad

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer18.10.2018 14:03Pressemelding

NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer. As a result, former Chief Medical Officer Juan Ruiz, M.D., Ph.D. will assume the role of Head of European Medical Affairs. The Company also announced the appointment of Neena Patil, J.D. as General Counsel and Corporate Secretary. Both Dr. Siffert and Ms. Patil report to Chief Executive Officer, Carsten Thiel, Ph.D. “I am very pleased to welcome João and Neena to Abeona, and confident in their abilities to make important contributions to the future growth of our company,” said Dr. Thiel. “João has an ideal blend of clinical, scientific, and regulatory experience to reference as we look to advance our clinical and pre-clinical can

Meltwater and Dow Jones Announce Global Partnership to Provide Premium Content18.10.2018 14:00Pressemelding

SAN FRANCISCO and NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Meltwater, a global leader in media intelligence, today announces the launch of a partnership with Dow Jones, a global provider of news and business information, to provide premium licensed content from Dow Jones Factiva into the Meltwater Media Intelligence platform. This partnership will give Meltwater’s PR and communications clients the ability to monitor and analyze premium licensed content across thousands of Factiva news sources globally, including: The Wall Street Journal, America’s largest newspaper by paid circulation; Barron’s; MarketWatch; and Dow Jones Newswires. “Meltwater provides our clients with the most comprehensive content network globally, across news, social media and broadcast media. This new Dow Jones partnership will further strengthen our leadership position and allow our clients to access licensed content from some of the most highly-respected news outlets in the world. We’re excited about this part

Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting18.10.2018 13:30Pressemelding

EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster session. Data to be presented across the Alzheimer’s disease clinical development portfolio, including aducanumab, BAN2401 and elenbecestat CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) announced it will present data from its Alzheimer’s disease (AD) clinical development portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting in Barcelona, Spain (October 24-27). The data being presented are part of Biogen’s ongoing research programs targeting possible causes of the disease through multiple modalities. “We are excited to engage with the scientific community at CTAD, to share learnings from our Alzheimer’s disease clinical research and to learn from the work of our colleagues around the world. We have hopes that our

SEMAFO Provides Notice of Third Quarter 2018 Results Release and Conference Call   18.10.2018 13:30Pressemelding

MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- SEMAFO (TSX, OMX: SMF) invites you to participate in a conference call on November 7, 2018 at 10:00 AM EST with senior management during which they will review the Corporation's third quarter 2018 financial and operational results. SEMAFO's financial statements and management's discussion and analysis for the third quarter 2018 will be released on November 6 after market hours and will be available in the “Investor Relations” section of the Corporation's website at www.semafo.com , and on the Canadian Securities Administrators' website at www.sedar.com . A live audio webcast of the conference call will be accessible for a period of 30 days through SEMAFO’s website at www.semafo.com . Tel. local & overseas: +1 (647) 788 4922 Tel. North America: 1 (877) 223 4471 Webcast: www.semafo.com Replay overseas: +1 (416) 621 4642 Replay N. America: 1 (800) 585 8367 Replay pass code: 2823689 Expiration: December 7, 2018 About SEMAFO SEMAFO is a Canadian-b

Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA18.10.2018 13:30Pressemelding

TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- (CSE: BIO) – Biome Grow (“Biome” or the “Company”) (CSE:BIO) is pleased to announce that the Company’s common shares have been listed on the Frankfurt Stock Exchange under the trading symbol “6OTA”. The Company’s common shares continue to be listed on the Canadian Securities Exchange (“CSE”) under the trading symbol “BIO”. “Biome is developing its production base in Canada with an eye to becoming a leader in the international medical cannabis market. Listing on the Frankfurt Stock Exchange will give Biome increased access to European and other international investors and positions Biome well for international growth and development opportunities,” said CEO Khurram Malik. The Frankfurt Stock Exchange is one of the world’s largest trading centres for securities. With a share in turnover of around 90 per cent, it is the largest of Germany’s seven stock exchanges and it is an international trading centre, which is reflected in the structure of its

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom